The Role of Abbreviated Breast MRI in High-Risk Screening and DCIS Detection
Recent presentations at ECR 2024 shed light on the efficacy of abbreviated breast MRI not only in high-risk women but also in evaluating “pure” ductal carcinoma in situ (DCIS). This innovative approach offers a safe and streamlined alternative to conventional breast MRI screening exams, as discussed by presenters Dr. Tamara Suaris and Dr. Nurbanu Basdogan….